R. Woods
Director/Board Member en X4 PHARMACEUTICALS, INC. .
Fortuna: 1 M $ al 31/03/2024
Perfil
En la actualidad, R. Keith Woods ocupa el cargo de Director de Operaciones de argenx SE. En su trayectoria profesional anterior, ocupó el cargo de SVP-North American Operations en Alexion Pharmaceuticals, Inc. y de Vicepresidente y Director General en Alexion Pharma UK Ltd. (una filial de Alexion Pharmaceuticals, Inc.). (una filial de Alexion Pharmaceuticals, Inc.). Se licenció en la Universidad Estatal de Florida.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ARGEN-X SE
0.01% | 20/02/2024 | 3 307 ( 0.01% ) | 1 M $ | 31/03/2024 |
X4 PHARMACEUTICALS, INC.
0.05% | 16/10/2023 | 90 000 ( 0.05% ) | 125 100 $ | 31/03/2024 |
Cargos activos de R. Woods
| Empresas | Cargo | Inicio |
|---|---|---|
| X4 PHARMACEUTICALS, INC. | Director/Board Member | 16/10/2023 |
| TSCAN THERAPEUTICS, INC. | Director/Board Member | 06/12/2023 |
| ROCKET PHARMACEUTICALS, INC. | Director/Board Member | 12/12/2023 |
Antiguos cargos conocidos de R. Woods.
| Empresas | Cargo | Fin |
|---|---|---|
| ARGENX SE | Chief Operating Officer | 13/03/2023 |
Alexion Pharma UK Ltd.
 Alexion Pharma UK Ltd. Medical DistributorsDistribution Services Part of AstraZeneca PLC, Alexion Pharma UK Ltd. is a pharmaceutical wholesaler founded in 2006. The private company is based in Middlesex, UK. | Corporate Officer/Principal | - |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formación de R. Woods.
| Florida State University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| ARGENX SE | Health Technology |
| ROCKET PHARMACEUTICALS, INC. | Health Technology |
| TSCAN THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
| X4 Pharmaceuticals, Inc. | |
Alexion Pharma UK Ltd.
Alexion Pharma UK Ltd. Medical DistributorsDistribution Services Part of AstraZeneca PLC, Alexion Pharma UK Ltd. is a pharmaceutical wholesaler founded in 2006. The private company is based in Middlesex, UK. | Distribution Services |
- Bolsa de valores
- Insiders
- R. Woods
